CAITONG SECURITIES CO.,LTD/ CNE100002V44 /
2024-06-05 9:00:00 AM | Chg. -0.02 | Volume | Bid2024-06-05 | Ask9:00:04 AM | High | Low |
---|---|---|---|---|---|---|
7.17CNY | -0.28% | 19.28 mill. Turnover: 138.62 mill. |
7.17Bid Size: 21,100 | 7.18Ask Size: 171,100 | 7.23 | 7.16 |
GlobeNewswire
5:17 PM
American Family Insurance Announces Newest Addition to its Brand Partnership Program
GlobeNewswire
5:15 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeu...
GlobeNewswire
5:10 PM
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Intel Corporation with Losses ...
GlobeNewswire
5:10 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Malibu Boats
GlobeNewswire
5:06 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fastly...
GlobeNewswire
5:05 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Autodesk
GlobeNewswire
5:00 PM
NCLA’s King George III Prize Recognizes Cardona and Mayorkas as the Worst Civil Liberties Violators
GlobeNewswire
5:00 PM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Equinix, Inc. with Losses to C...
GlobeNewswire
5:00 PM
Vishay Intertechnology Releases Second-Generation Automotive Grade IHLE® Inductor With Integrated EM...
GlobeNewswire
5:00 PM
Posifa Technologies to Showcase A2L Leak Detection and Hydrogen Sensors at Sensors Converge Expo
GlobeNewswire
4:58 PM
FSI ANNOUNCES CAPEX EXPENDITURE TO ACQUIRE A VIAL FILLING LINE FOR INJECTABLE DRUGS SUCH AS GLP1 FOR...
GlobeNewswire
4:55 PM
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
GlobeNewswire
4:51 PM
VPS AI Announces Strategic Partnership with Taiko: Ushering in a New Era of Blockchain Technology
GlobeNewswire
4:50 PM
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses...
GlobeNewswire
4:48 PM
Late Breaking Poster Shows a Novel Oral Insulin Sensitizer Azemiglitazone (MSDC-0602K) Could Substan...